InVivoMAb anti-human MUC1 (CD227)
BE0336
ApplicationsImmunoFluorescence, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin, Other Application
Product group Antibodies
ReactivityHuman
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-human MUC1 (CD227)
- Delivery Days Customer7
- ApplicationsImmunoFluorescence, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin, Other Application
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDC595 (NCRC48)
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostMouse
- IsotypeIgG3
- ReactivityHuman
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Wang L, Chen H, Pourgholami MH, et al. Anti-MUC1 monoclonal antibody (C595) and docetaxel markedly reduce tumor burden and ascites, and prolong survival in an in vivo ovarian cancer model. PLoS One. 2011,6(9):e24405. doi: 10.1371/journal.pone.0024405Read this paper
- Storr SJ, Royle L, Chapman CJ, et al. The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serum. Glycobiology. 2008,18(6):456-62. doi: 10.1093/glycob/cwn022Read this paper
- Qu CF, Li Y, Song YJ, et al. MUC1 expression in primary and metastatic pancreatic cancer cells for in vitro treatment by (213)Bi-C595 radioimmunoconjugate. Br J Cancer. 2004,91(12):2086-93.Read this paper